核受体调控胶质瘤PD-L1新机制( 二 )
本文插图
原文链接：
参考文献
1. Sophie B A , Barbara K , Georg W , et al. Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma[J]. Neuro-Oncology, 2015.
2. Cloughesy T F , Mochizuki A Y , Orpilla J R , et al. Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma[J]. Nature Medicine, 2019.
3. Zhu Z, Khan MA, Weiler M, et al. Targeting self-renewal in high-grade brain tumors leads to loss of brain tumor stem cells and prolonged survival.[J]. Cell Stem Cell, 2014.
4. Friebel E , Kapolou K , Unger S , et al. Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes[J]. Cell, 2020.
【核受体调控胶质瘤PD-L1新机制】5. Gordon S R , Maute R L , Dulken B W , et al. PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunity[J]. Nature, 2017.
推荐阅读
- 骨结核病人饮食禁忌有什么
- 肺结核饮食禁忌有哪些
- 核桃仁泡酒可以治病吗
- 适合肺结核病人的食谱
- 结核性胸膜炎饮食如何准备
- 核桃补肾效果最好的部位已经被你扔掉
- 肺结核吃什么食物好？这些食物是首选
- 腰椎结核病的饮食方面及注意事项
- 肺结核治疗期间水果选择
- 高血压能吃山核桃吗